Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1

被引:569
作者
Cartegni, L [1 ]
Krainer, AR [1 ]
机构
[1] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/ng854
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Alteration of correct splicing patterns by disruption of an exonic splicing enhancer may be a frequent mechanism by which point mutations cause genetic diseases. Spinal muscular atrophy results from the lack of functional survival of motor neuron 1 gene (SMN1), even though all affected individuals carry a nearly identical, normal SMN2 gene. SMN2 is only partially active because a translationally silent, single-nucleotide difference in exon 7 causes exon skipping. Using ESE motif-prediction tools, mutational analysis and in vivo and in vitro splicing assays, we show that this single-nucleotide change occurs within a heptamer motif of an exonic splicing enhancer, which in SMN1 is recognized directly by SF2/ASF. The abrogation of the SF2/ASF-dependent ESE is the basis for inefficient inclusion of exon 7 in SMN2, resulting in the spinal muscular atrophy phenotype.
引用
收藏
页码:377 / 384
页数:8
相关论文
共 50 条
[1]   Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients [J].
Andreassi, C ;
Jarecki, J ;
Zhou, JH ;
Coovert, DD ;
Monani, UR ;
Chen, XC ;
Whitney, M ;
Pollok, B ;
Zhang, ML ;
Androphy, E ;
Burghes, AHM .
HUMAN MOLECULAR GENETICS, 2001, 10 (24) :2841-2849
[2]   Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1 [J].
Ars, E ;
Serra, E ;
García, J ;
Kruyer, H ;
Gaona, A ;
Lázaro, C ;
Estivill, X .
HUMAN MOLECULAR GENETICS, 2000, 9 (02) :237-247
[3]   Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases [J].
Blencowe, BJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) :106-110
[4]  
Burge CB, 1999, RNA WORLD, P525
[5]  
CACERES JF, 1997, EUKARYOTIC MRNA PROC, P174
[6]   Treatment of spinal muscular atrophy by sodium butyrate [J].
Chang, JG ;
Hsieh-Li, HM ;
Jong, YJ ;
Wang, NM ;
Tsai, CH ;
Li, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (17) :9808-9813
[7]   Identification of a new class of exonic splicing enhancers by in vivo selection [J].
Coulter, LR ;
Landree, MA ;
Cooper, TA .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) :2143-2150
[8]  
Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U
[9]   A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers [J].
Graveley, BR ;
Hertel, KJ ;
Maniatis, T .
EMBO JOURNAL, 1998, 17 (22) :6747-6756
[10]   Correspondence - SR proteins are 'locators' of the RNA splicing machinery [J].
Graveley, BR ;
Hertel, KJ ;
Maniatis, T .
CURRENT BIOLOGY, 1999, 9 (01) :R6-R7